Article
HPGDS as a biomarker for prognosis and immunotherapy in pancreatic cancer
2025-05-19
Abstract excerpt
<title>Abstract</title> <p>Pancreatic ductal adenocarcinoma (PDAC), a highly aggressive malignancy with a poor prognosis, is partly attributed to its immunosuppressive microenvironment. Hematopoietic prostaglandin D synthase (HPGDS), a key enzyme in prostaglandin D2 biosynthesis, plays a significant role in lipid metabolism and inflammatory signalling. Here, we comprehensively investigated the expression profile,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 39cd23d5-8790-5afa-b2db-8b0f37cae4ad
- DOI
- 10.21203/rs.3.rs-6637568/v1
